Screener
Xeris Biopharma Holdings, Inc. XERS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Trade accounts receivable, net | 58,105 | 51,050 |
| Inventory, net | 80,930 | 68,673 |
| Prepaid expenses and other current assets | 13,975 | 9,548 |
| Total current assets | 274,757 | 240,313 |
| Property and equipment, net | 4,834 | 4,945 |
| Operating lease right-of-use assets | 21,773 | 22,112 |
| Goodwill | 22,859 | 22,859 |
| Intangible assets, net | 82,657 | 88,078 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Xeris Biopharma Holdings, Inc.'s total current assets?
- Xeris Biopharma Holdings, Inc. (XERS) reported total current assets of $274.76M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s total current assets changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s total current assets increased by 48.1% year-over-year, from $185.58M to $274.76M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s total current assets has grown at a 9.6% compound annual growth rate (CAGR), from $152.21M to $240.31M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Xeris Biopharma Holdings, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude